Danese S, Vermeire S, D'Haens G, Panes J, et al. Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trial. Lancet Gastroenterol Hepatol 2022;7:294-306.
PMID: 35120656